Biosyent Inc (TSXV:RX)
C$ 11 -0.15 (-1.35%) Market Cap: 127.46 Mil Enterprise Value: 111.19 Mil PE Ratio: 18.36 PB Ratio: 3.60 GF Score: 96/100

Q1 2022 Biosyent Inc Earnings Presentation Transcript

May 18, 2022 / NTS GMT
Release Date Price: C$8.36 (-5.54%)
RenÃ;C. Goehrum
BioSyent Inc. - Chairman, CEO & President

Presentation
May 18, 2022 / NTS GMT

=====================
Corporate Participants
=====================
* René C. Goehrum
BioSyent Inc. - Chairman, CEO & President

=====================
© -

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot